Achote E, Arroyo Ripoll OF, Araujo-Castro M. Update on the diagnosis of the pheochromocytoma. Hipertens y Riesgo Vasc. 2024. https://doi.org/10.1016/J.HIPERT.2024.08.001.

Lenders JWM, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SKG, Murad MH, et al. Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline. Endocr Soc. 2014;99. https://doi.org/10.1210/jc.2014-1498.

Cascón A, Robledo M. Clinical and molecular markers guide the genetics of pheochromocytoma and paraganglioma. Biochim Biophys Acta Rev Cancer. 2024;1879. https://doi.org/10.1016/J.BBCAN.2024.189141.

Castro-Teles J, Sousa-Pinto B, Rebelo S, Pignatelli D. Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: not a needle in a haystack. Endocr Connect. 2021;10:R293-304. https://doi.org/10.1530/EC-21-0294.

Article  PubMed  PubMed Central  Google Scholar 

von Hippel-Lindau disease: a clinical and scientific review - PubMed n.d. https://pubmed.ncbi.nlm.nih.gov/21386872/. Accessed December 17, 2024.

Castinetti F, Maia AL, Peczkowska M, Barontini M, Hasse-Lazar K, Links TP, et al. The penetrance of MEN2 pheochromocytoma is not only determined by RET mutations. Endocr Relat Cancer. 2017;24:L63–7. https://doi.org/10.1530/ERC-17-0189.

Article  PubMed  Google Scholar 

Sarkadi B, Saskoi E, Butz H, Patocs A. Genetics of pheochromocytomas and paragangliomas determine the therapeutical approach. 2022;2(3):1450.

Google Scholar 

Iacobone M, Belluzzi A, Torresan F. Surgical approaches and results of treatment for hereditary paragangliomas. Best Pract Res Clin Endocrinol Metab. 2019;33. https://doi.org/10.1016/j.beem.2019.101298.

Castinetti F, Taieb D, Henry JF, Walz M, Guerin C, Brue T, et al. Management of endocrine disease: outcome of adrenal sparing surgery in heritable pheochromocytoma. Eur J Endocrinol. 2016;174:R9-18. https://doi.org/10.1530/EJE-15-0549.

Article  PubMed  CAS  Google Scholar 

Edström E, Gröndal S, Norström F, Palmér M, Svensson KA, Widell H, et al. Long term experience after subtotal adrenalectomy for multiple endocrine neoplasia type IIa. Eur J Surg. 1999;165:431–5. https://doi.org/10.1080/110241599750006659.

Article  PubMed  Google Scholar 

Brauckhoff M, Nguyen Thanh P, Bär A, Dralle H. Subtotal bilateral adrenalectomy preserving adrenocortical function. Chirurg. 2003;74:646–51. https://doi.org/10.1007/S00104-002-0608-0.

Article  PubMed  CAS  Google Scholar 

Rubalcava NS, Overman RE, Kartal TT, Bruch SW, Else T, Newman EA. Laparoscopic adrenal-sparing approach for children with bilateral pheochromocytoma in Von Hippel-Lindau disease. J Pediatr Surg. 2022;57:414–7. https://doi.org/10.1016/J.JPEDSURG.2021.04.007.

Article  PubMed  Google Scholar 

Shirali AS, Clemente-Gutierrez U, Huang BL, Lui MS, Chiang YJ, Jimenez C, et al. Pheochromocytoma recurrence in hereditary disease: does a cortical-sparing technique increase recurrence rate? Surgery. 2023;173:26–34. https://doi.org/10.1016/J.SURG.2022.05.003.

Article  PubMed  Google Scholar 

Walz MK, Peitgen K, Diesing D, Petersenn S, Janssen OE, Philipp T, et al. Partial versus total adrenalectomy by the posterior retroperitoneoscopic approach: early and long-term results of 325 consecutive procedures in primary adrenal neoplasias. World J Surg. 2004;28:1323–9. https://doi.org/10.1007/S00268-004-7667-Y.

Article  PubMed  Google Scholar 

Walz MK, Peitgen K, Saller B, Giebler RM, Lederbogen S, Nimtz K, et al. Subtotal adrenalectomy by the posterior retroperitoneoscopic approach. World J Surg. 1998;22:621–7. https://doi.org/10.1007/S002689900444.

Article  PubMed  CAS  Google Scholar 

Alesina PF, Hinrichs J, Meier B, Schmid KW, Neumann HPH, Walz MK. Minimally invasive cortical-sparing surgery for bilateral pheochromocytomas. Langenbeck’s Arch Surg. 2012;397:233–8. https://doi.org/10.1007/S00423-011-0851-2.

Article  Google Scholar 

Diner EK, Franks ME, Behari A, Linehan WM, Walther MM. Partial adrenalectomy: the national cancer institute experience. Urology. 2005;66:19–23. https://doi.org/10.1016/J.UROLOGY.2005.01.009.

Article  PubMed  Google Scholar 

Pautler SE, Choyke PL, Pavlovich CP, Daryanani K, Walther MM. Intraoperative ultrasound aids in dissection during laparoscopic partial adrenalectomy. J Urol. 2002;168:1352–5. https://doi.org/10.1016/S0022-5347(05)64447-3.

Article  PubMed  Google Scholar 

Boris RS, Gupta G, Linehan WM, Pinto PA, Bratslavsky G. Robot-assisted laparoscopic partial adrenalectomy: initial experience. Urology. 2011;77:775–80. https://doi.org/10.1016/J.UROLOGY.2010.07.501.

Article  PubMed  Google Scholar 

Asher KP, Gupta GN, Boris RS, Pinto PA, Linehan WM, Bratslavsky G. Robot-assisted laparoscopic partial adrenalectomy for pheochromocytoma: the national cancer institute technique. Eur Urol. 2011;60:118–24. https://doi.org/10.1016/J.EURURO.2011.03.046.

Article  PubMed  PubMed Central  Google Scholar 

Sanford TH, Storey BB, Linehan WM, Rogers CA, Pinto PA, Bratslavsky G. Outcomes and timing for intervention of partial adrenalectomy in patients with a solitary adrenal remnant and history of bilateral phaeochromocytomas. BJU Int. 2011;107:571–5. https://doi.org/10.1111/J.1464-410X.2010.09568.X.

Article  PubMed  Google Scholar 

Volkin D, Yerram N, Ahmed F, Lankford D, Baccala A, Gupta GN, et al. Partial adrenalectomy minimizes the need for long-term hormone replacement in pediatric patients with pheochromocytoma and von Hippel-Lindau syndrome. J Pediatr Surg. 2012;47:2077–82. https://doi.org/10.1016/J.JPEDSURG.2012.07.003.

Article  PubMed  Google Scholar 

Neumann HPH, Bender BU, Reincke M, Eggstein S, Laubenberger J, Kirste G. Adrenal-sparing surgery for phaeochromocytoma. Br J Surg. 1999;86:94–7.

Article  PubMed  CAS  Google Scholar 

Nockel P, El Lakis M, Gaitanidis A, Yang L, Merkel R, Patel D, et al. Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery. Surgery. 2018;163:191–6. https://doi.org/10.1016/J.SURG.2017.05.025.

Article  PubMed  Google Scholar 

Rajan S, Zaidi G, Agarwal G, Mishra A, Agarwal A, Mishra SK, et al. Genotype-phenotype correlation in indian patients with MEN2-associated pheochromocytoma and comparison of clinico-pathological attributes with apparently sporadic adrenal pheochromocytoma. World J Surg. 2016;40:690–6. https://doi.org/10.1007/S00268-015-3255-6.

Article  PubMed  Google Scholar 

Janetschek G, Finkenstedt G, Gasser R, Waibel UG, Peschel R, Bartsch G, et al. Laparoscopic surgery for pheochromocytoma: adrenalectomy, partial resection, excision of paragangliomas. J Urol. 1998;160:330–4. https://doi.org/10.1016/S0022-5347(01)62886-6.

Article  PubMed  CAS  Google Scholar 

Inabnet WB, Caragliano P, Pertsemlidis D. Pheochromocytoma: inherited associations, bilaterality, and cortex preservation. Surgery. 2000;128:1007–12. https://doi.org/10.1067/MSY.2000.110846.

Article  PubMed  CAS  Google Scholar 

Kittah NE, Gruber LM, Bancos I, Hamidi O, Tamhane S, Iñiguez-Ariza N, et al. Bilateral pheochromocytoma: clinical characteristics, treatment and longitudinal follow-up. Clin Endocrinol (Oxf). 2020;93:288–95. https://doi.org/10.1111/cen.14222.

Article  PubMed  CAS  Google Scholar 

Lee JE, Curley SA, Gagel RF, Evans DB, Hickey RC, Pasieka JL, et al. Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma. Surgery. 1996;120:1064–71. https://doi.org/10.1016/S0039-6060(96)80056-0.

Article  PubMed  CAS  Google Scholar 

Neumann HPH, Tsoy U, Bancos I, Amodru V, Walz MK, Tirosh A, et al. Comparison of pheochromocytoma-specific morbidity and mortality among adults with bilateral pheochromocytomas undergoing total adrenalectomy vs cortical-sparing adrenalectomy. JAMA Netw Open. 2019;2:E198898. https://doi.org/10.1001/JAMANETWORKOPEN.2019.8898.

Article  PubMed  PubMed Central  Google Scholar 

Pugliese R, Boniardi M, Sansonna F, Maggioni D, De Carli S, Costanzi A, et al. Outcomes of laparoscopic adrenalectomy. Clinical experience with 68 patients. Surg Oncol. 2008;17:49–57. https://doi.org/10.1016/J.SURONC.2007.09.004.

Article  PubMed  Google Scholar 

Sanford T, Gomella PT, Siddiqui R, Su D, An JY, Bratslavsky G, et al. Long term outcomes for patients with von Hippel-Lindau and pheochromocytoma: defining the role of active surveillance. Urol Oncol. 2021;39:134.e1-134.e8. https://doi.org/10.1016/J.UROLONC.2020.11.019.

Article  PubMed  CAS  Google Scholar 

Scholten A, Valk GD, Ulfman D, Borel RIHM, Vriens MR. Unilateral subtotal adrenalectomy for pheochromocytoma in multiple endocrine neoplasia type 2 patients: a feasible surgical strategy. Ann Surg. 2011;254:1022–7. https://doi.org/10.1097/SLA.0B013E318237480C.

Article  PubMed  Google Scholar 

Simforoosh N, Soltani MH, Shemshaki H, Hashemi MB, Dadpour M, Kashi AH. Symptom resolution and recurrence outcome